Policies, reports and codes
Highlighted resources
Equity, diversity and inclusion at LifeArc
We aim to foster an environment that is collaborative and inclusive for our people, our partners and our beneficiaries.
Our commitment to the environment
Environmental impact forms an important part of LifeArc’s overall commitment to society.
Supplier information
Information on how we procure our products and services, and our Supplier Code of Conduct.
Other documents
-
Read more: Statement on the use of animals in research
LifeArc progresses promising early-stage science to tackle some of the biggest challenges facing human health. We do this by funding science, forming partnerships, and providing scientific and Intellectual Property protection services. We believe the use of animals in scientific research is sometimes a necessary tool in improving our understanding of how biological systems work both…
-
Read more: Articles of association
Details of our charity registration and a summary of our charitable purposes.
-
-
Read more: LifeArc representation – Spring Budget 2023
Government has rightly identified innovation as a growth priority. Fuelling key innovation sectors will be vital to growth, not least our life science industry which generated £94.2 billion in 2021. The UK has an exceptional science base, and global access to capital and talent to fuel the growth of life sciences companies domestically.
-
Read more: Modern Slavery Statement
View the statement for 2023 and access past statements.
-
Read more: Gender pay gap report 2021-22
Download the current report and view previous years’ reports
Latest news
-
LifeArc launches £40m research centres that will unlock new tests, treatments and cures for people living with rare diseases
Read more: LifeArc launches £40m research centres that will unlock new tests, treatments and cures for people living with rare diseases -
First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases
Read more: First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases -
New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya
Read more: New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya